Effects of Recombinant Erythropoietin on Breast Cancer-Initiating Cells

Effects of Recombinant Erythropoietin on Breast Cancer-Initiating Cells

BACKGROUND: Cancer anemia causes fatigue and correlates with poor treatment outcome. Erythropoietin has been introduced in an attempt to correct these defects. However, five recent clinical trials reported a negative impact of erythropoietin on survival and/or tumor control, indicating that experime...

Full description

Bibliographic Details
Main Authors:	Tiffany M. Phillips, Kwanghee Kim, Erina Vlashi, William H. McBride, Frank Pajonk
Format:	Article
Language:	English
Published:	Elsevier 2007-12-01
Series:	Neoplasia: An International Journal for Oncology Research
Subjects:	CD24ࢤ/low/CD44+ breast cancer cells breast cancer-initiating cells rhEpo Notch Epor
Online Access:	http://www.sciencedirect.com/science/article/pii/S1476558607801229

Similar Items

Comparison of Immobilized Metal Affinity Chromatography Ni-NTA and Co-TALON for the Purification of Recombinant Human Erythropoietin
by: Yana Rubiyana, et al.
Published: (2015-12-01)

Soluble expression and partial purification of recombinant human erythropoietin from E. coli
by: Jeong, Taeck-Hyun, et al.
Published: (2016)

The Role of Erythropoietin in Preventing Anemia in the Premature Neonate
by: Oana Cristina Costescu, et al.
Published: (2023-11-01)

Erythropoietin treatment enhances mitochondrial function in human skeletal muscle
by: Ulla ePlenge, et al.
Published: (2012-03-01)

Erythropoietin Receptor (EpoR) Agonism Is Used to Treat a Wide Range of Disease
by: Fabian Sanchis-Gomar, et al.
Published: (2013-04-01)

Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice
by: Zamzam Awida, et al.
Published: (2022-10-01)

Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patients
by: Abdel-Rahman N. Zekri, et al.
Published: (2022-12-01)

Editorial: Insights in Anti-doping Sciences: 2021
by: Raphael Faiss
Published: (2023-04-01)

Role of Erythropoietin Receptor Signaling in Macrophages or Choroidal Endothelial Cells in Choroidal Neovascularization
by: Aniket Ramshekar, et al.
Published: (2022-07-01)

Erythropoetin and erythropoetin receptor systems, and oxidative status in patients with basal cell
by: Ergul Belge Kurutas, et al.
Published: (2021-08-01)

A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
by: Mahdi Abdoli Shadbad, et al.
Published: (2021-08-01)

The Effects of Curcumae Longae Radix, Curcuma phaeocaulis Radix and Their Processed Products on Epo/EpoR Pathway and CD62p
by: Zhimin Chen, et al.
Published: (2018-07-01)

Serum erythropoietin levels, breast cancer and breast cancer-initiating cells
by: Kruttika Bhat, et al.
Published: (2019-01-01)

MicroRNA 628 Suppresses Migration and Invasion of Breast Cancer Stem Cells through Targeting SOS1 [Retraction]
by: Lin C, et al.
Published: (2023-06-01)

EPOR mRNA level: A valuable prognostic indicator for patients with ER+ breast cancer
by: Jing Pan, et al.
Published: (2018-01-01)

In silico designing and expression of novel recombinant construct containing the variable part of CD44 extracellular domain for prediagnostic breast cancer
by: Elaheh Gheybi, et al.
Published: (2023-03-01)

HER2-expressing breast tumors are associated with breast cancer stem-cell phenotype CD44+/CD24-
by: Iris Rabinovich, et al.
Published: (2018-10-01)

Tumorigenic and Metastatic Role of CD44<sup>−/low</sup>/CD24<sup>−/low</sup> Cells in Luminal Breast Cancer
by: Rajeev Vikram, et al.
Published: (2020-05-01)

Protein abundance of AKT and ERK pathway components governs cell type‐specific regulation of proliferation
by: Lorenz Adlung, et al.
Published: (2017-01-01)

The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential Targeting
by: Olivia L. Walker, et al.
Published: (2022-01-01)

Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro
by: Maxim Olsson, et al.
Published: (2023-09-01)

Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses
by: Sebastien Taurin, et al.
Published: (2020-12-01)

EpoR Activation Stimulates Erythroid Precursor Proliferation by Inducing Phosphorylation of Tyrosine-88 of the CDK-Inhibitor p27<sup>Kip1</sup>
by: Fragka Pegka, et al.
Published: (2023-06-01)

Breast Cancer Classification Based on Tumor Budding and Stem Cell-Related Signatures Facilitate Prognosis Evaluation
by: Zhenxian Xiang, et al.
Published: (2022-01-01)

Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
by: Javier Enciso-Benavides, et al.
Published: (2021-06-01)

CD44/CD24 Expression in recurrent gastric cancer: a retrospective analysis
by: Yong Ching-Shya, et al.
Published: (2012-07-01)

CD44 Expression Profile Varies According to Maturational Subtypes and Molecular Profiles of Pediatric T-Cell Lymphoblastic Leukemia
by: Luísa Vieira Codeço Marques, et al.
Published: (2018-10-01)

Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy
by: Pham Phuc V, et al.
Published: (2011-12-01)

SIPA1 enhances SMAD2/3 expression to maintain stem cell features in breast cancer cells
by: Ning Wang, et al.
Published: (2020-12-01)

Hinokitiol Inhibits Breast Cancer Cells In Vitro Stemness-Progression and Self-Renewal with Apoptosis and Autophagy Modulation via the CD44/Nanog/SOX2/Oct4 Pathway
by: Yi-Fen Chiang, et al.
Published: (2024-03-01)

Expression of cancer stem cell marker CD44 and axillary lymph node metastasis in invasive ductal carcinoma of breast
by: P. Anusha, et al.
Published: (2024-04-01)

Enrichment of CD44 in Exosomes From Breast Cancer Cells Treated With Doxorubicin Promotes Chemoresistance
by: Xiaohong Wang, et al.
Published: (2020-07-01)

Preparation of chitosan nanoparticle containing recombinant CD44v antigen and evaluation of its immunization capacity against breast cancer in BALB/c mice
by: Elaheh Gheybi, et al.
Published: (2023-02-01)

Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro
by: Goyette S, et al.
Published: (2017-05-01)

CD44+/CD24- Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study
by: Unedo Hence Markus Sihombing, et al.
Published: (2022-10-01)

Cancer stem cell markers in intraoral minor salivary gland tumors
by: Benay Yıldırım, et al.
Published: (2022-06-01)

Caesalpinia sappan reduces the stemness of breast cancer stem cells involving the elevation of intracellular reactive oxygen species
by: Riris Istighfari Jenie, et al.
Published: (2023-01-01)

The v8-10 variant isoform of CD44 is selectively expressed in the normal human colonic stem cell niche and frequently is overexpressed in colon carcinomas during tumor development
by: Bruce M. Boman, et al.
Published: (2023-12-01)

CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro?
by: Ruizhi Geng, et al.
Published: (2022-05-01)

Characteristics of Cancer Stem Cells and Their Potential Role in Endometrial Cancer
by: Karolina Frąszczak, et al.
Published: (2024-03-01)